Loading clinical trials...

A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT00042328

A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients

The purpose of this research is to study the pharmacology (how the body handles this drug) of valacyclovir in children receiving treatment for cancer. This study will last approximately 7 days.

Lead sponsor: Baylor College of Medicine•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

DeniLA: Comprehensive Demographics and Clinical Profile of NSCLC Patients: Analyzing Guideline-Concordant Care in First-line Treatment Patterns

NCT07109154 · Lung Neoplasms

RECRUITINGPhase 3

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

NCT06919965 · Non-Muscle Invasive Bladder Neoplasms

RECRUITINGPhase 1/2

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

NCT06380816 · Advanced Solid Tumours, Squamous Cell Carcinoma of Head and Neck, and more

RECRUITING

Biospecimen Procurement for Head and Neck Disorders

NCT03429036 · Hearing Disorder, Oral Mucosal Disease, and more

RECRUITINGPhase 2

Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

NCT03206060 · Pheochromocytoma, Paraganglioma, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 24, 2015Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment30

Start dateAug 2001

Last updatedAug 24, 2015

Condition

Neoplasms

Locations shown

Texas Children's Hospital

Houston, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 24, 2015Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions